Piper Sandler started coverage on shares of Aemetis (NASDAQ:AMTX – Get Rating) in a research report report published on Monday, The Fly reports. The brokerage issued an underweight rating on the specialty chemicals company’s stock.
AMTX has been the topic of several other research reports. UBS Group assumed coverage on Aemetis in a research note on Tuesday, December 13th. They set a neutral rating and a $4.25 target price on the stock. Ascendiant Capital Markets decreased their target price on shares of Aemetis to $26.00 in a research report on Wednesday, November 16th. Finally, Truist Financial decreased their price objective on Aemetis from $9.00 to $5.00 and set a hold rating on the stock in a research report on Wednesday, February 1st. Two analysts have rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Aemetis presently has a consensus rating of Hold and an average target price of $15.56.
Aemetis Price Performance
Shares of AMTX stock opened at $3.85 on Monday. The company has a market cap of $134.90 million, a price-to-earnings ratio of -1.49 and a beta of 0.87. Aemetis has a 1 year low of $3.62 and a 1 year high of $16.06. The firm has a fifty day moving average price of $4.18 and a 200-day moving average price of $5.95.
Institutional Trading of Aemetis
Aemetis Company Profile
Aemetis, Inc is a renewable fuels and biochemical company, which engages in the acquisition, development, and commercialization of technologies that replace traditional petroleum-based products. It operates through the North America and India geographical segments. The North America segment manages Keyes Plant in California, the cellulosic ethanol facility in Riverbank, the cluster of biogas digesters on dairies near Keyes, California, the Goodland Plant, Kansas and the research and development facility in Minnesota.
- Get a free copy of the StockNews.com research report on Aemetis (AMTX)
- Reserve Your Spot With These Hotels The Analysts Support
- Cruise Line Stocks Still Have Some Choppy Waters to Navigate
- Four Vegan Food Stocks Performing Beyond the Norm
- Ocean Interest Electrifies Fisker Stock
- Is Freshpet Ready For A Fresh Rally?
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.